切换至 "中华医学电子期刊资源库"

中华肾病研究电子杂志 ›› 2018, Vol. 07 ›› Issue (05) : 231 -233. doi: 10.3877/cma.j.issn.2095-3216.2018.05.009

所属专题: 指南与规范 文献 指南共识

综述

日本血管通路2015指南解读
刘佳玮1, 王荣2, 武杏1, 伍刚1,()   
  1. 1. 116023 辽宁省,大连医科大学;225001 江苏省,扬州大学临床医学院 江苏省苏北人民医院
    2. 225001 江苏省,扬州大学临床医学院 江苏省苏北人民医院
  • 收稿日期:2018-03-28 出版日期:2018-10-28
  • 通信作者: 伍刚

Interpretation of the Japanese 2015 guidelines for vascular access: establishment of difficult vascular access and treatment strategies for its complications

Jiawei Liu1, Rong Wang2, Xing Wu1, Gang Wu1,()   

  1. 1. Dalian Medical University, Dalian 116023, Liaoning Province; Jiangsu Provincial Subei People′s Hospital, Yangzhou University Clinical Medical College, Yangzhou 225001, Jiangsu Province; China
    2. Jiangsu Provincial Subei People′s Hospital, Yangzhou University Clinical Medical College, Yangzhou 225001, Jiangsu Province; China
  • Received:2018-03-28 Published:2018-10-28
  • Corresponding author: Gang Wu
  • About author:
    Corresponding author: Wu Gang, Email:
引用本文:

刘佳玮, 王荣, 武杏, 伍刚. 日本血管通路2015指南解读[J/OL]. 中华肾病研究电子杂志, 2018, 07(05): 231-233.

Jiawei Liu, Rong Wang, Xing Wu, Gang Wu. Interpretation of the Japanese 2015 guidelines for vascular access: establishment of difficult vascular access and treatment strategies for its complications[J/OL]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2018, 07(05): 231-233.

随着患者生存率的逐年增高、老龄化、慢性病患者和糖尿病肾病患者的增加,血管通路耗竭的情况越来越常见,血管通路的建立及其修复也越来越困难;血管通路、移植物血管通路及动脉浅表化穿刺的建立及其并发症的预防、处理策略,将会成为影响血液透析水平的重要因素。本文就日本血管通路指南中移植物血管通路(AVG)、动脉浅表化建立及围手术期管理做一概述。

With the increases of patient survival rate, aging, chronic disease and diabetic nephropathy, the depletion of vascular access is becoming more common, and the establishment and repair of vascular access are becoming more and more difficult. The establishment of vascular access, graft vascular access, and superficial arterial puncture as well as the prevention and treatment strategies of complications will become important factors affecting the level of hemodialysis. This article provided an overview of the arteriovenous grafts (AVG) access, the establishment of arteries superficialization, and perioperative management according to the Japanese 2015 guidelines for vascular access.

图1 移植物血管通路插管部位感染处理流程图
表1 动脉浅表化手术适应症[1]
[1]
Kukita K, Ohira S, Amano I, et al. 2011 update Japanese Society for Dialysis Therapy guidelines of vascular access construction and repair for chronic hemodialysis [J]. Ther Apher Dial, 2015, 19 (Suppl 1): 1-39.
[2]
Akoh J. Prosthetic arteriovenous grafts for hemodialysis [J]. J Vasc Access, 2009, 10(3): 137-147.
[3]
Kherlakian GM, Roedersheimer LR, Arbaugh JJ, et al. Comparison of autogenous fistula versus expanded polytetrafluoroethylene graft fistula for angioaccess in hemodialysis [J]. Am J Surg, 1986, 152(2): 238-243.
[4]
Ota K, Tsuji Y, Kukita K. Long-term outcome of Terumo vascular graft (GRASIL®) for hemodialysis [J]. J Jpn Soc Dial Ther, 2006, 39: 1395-1401.
[5]
Dixon BS, Beck GJ, Vazquez MA, et al. Effect of dipyridamole plus aspirin on hemodialysis graft patency [J]. N Engl J Med, 2009, 360(21): 2191-2201.
[6]
Blumenberg RM, Gelfand ML, Dale WA. Perigraft seromas complicating arterial grafts [J]. Surgery, 1985, 97(2): 194-204.
[7]
Gargiulo NR, Veith FJ, Scher LA, et al. Experience with covered stents for the management of hemodialysis polytetrafluoroethylene graft seromas [J]. J Vasc Surg, 2008, 48(1): 216-217.
[8]
Dauria DM, Dyk P, Garvin P. Incidence and management of seroma after arteriovenous graft placement [J]. J Am Coll Surg, 2006, 203(4): 506-511.
[9]
Powe NR, Jaar B, Furth SL, et al. Septicemia in dialysis patients: incidence, risk factors, and prognosis [J]. Kidney Int, 1999, 55(3): 1081-1090.
[10]
Amano I, Ohira S, Goto Y, et al. In preparation for a treatment guideline for suitable vascular access repair in Japan [J]. Ther Apher Dial, 2006, 10(4): 364-371.
[11]
D′Cunha PT, Besarab A. Vascular access for hemodialysis: 2004 and beyond [J]. Curr Opin Nephrol Hypertens, 2004, 13(6): 623-629.
[12]
Glickman M, Stokes G, Ross J. Multicenter evaluation of a polyurethaneurea vascular access graft as compared with the expanded polytetrafluoroethylene vascular access graft in hemodialysis applications [J]. J Vasc Surg, 2001, 34(3): 465-473.
[13]
Sakka SG, Reinhart K, Wegscheider K, et al. Comparison of cardiac output and circulatory blood volumes by transpulmonary thermo-dye dilution and transcutaneous indocyanine green measurement in critically ill patients [J]. Chest, 2002, 121(2): 559-565.
[14]
Earley A, Persson R, Raman G. III. NKF-K/DOQI clinical practice guidelines for vascular access: update 2000 [J]. Am J Kidney Dis, 2001, 37(1 Suppl 1): S137-S181.
[15]
Turmel-Rodrigues L, Pengloan J, Blanchier D. Insufficient dialysis shunts: improved long term patency rates with close hemodynamic monitering, repeated percutaneous balloon angioplasty, and stent placement [J]. Radiology, 1993, 187: 273-278.
[16]
Degawa H, Tagawa H, Tomikawa S. Long-term outcome of expanded polytetrafluoroethylene graft for hemodialysis access [J]. J Jpn Soc Dial Ther, 1995, 28: 1359-1365.
[17]
Bhatia DS, Money SR, Ochsner JL, et al. Comparison of surgical bypass and percutaneous balloon dilatation with primary stent placement in the treatment of central venous obstruction in the dialysis patient: one-year follow-up [J]. Ann Vasc Surg, 1996, 10(5): 452-455.
[18]
Kovalik EC, Newman GE, Suhocki P, et al. Correction of central venous stenoses: use of angioplasty and vascular Wallstents [J]. Kidney Int, 1994, 45(4): 1177-1181.
[19]
Poulain F, Raynaud A, Bourquelot P, et al. Local thrombolysis and thromboaspiration in the treatment of acutely thrombosed arteriovenous hemodialysis fistulas [J]. Cardiovasc Intervent Radiol, 1991, 14(2): 98-101.
[20]
Gmelin E, Winterhoff R, Rinast E. Insufficient hemodialysis access fistulas: late results of treatment with percutaneous balloon angioplasty [J]. Radiology, 1989, 171(3): 657-660.
[21]
Trerotola SO, Davidson DD, Filo RS, et al. Preclinical in vivo testing of a rotational mechanical thrombolytic device [J]. J Vasc Interv Radiol, 1996, 7(5): 717-723.
[22]
Ohira S, Naito H, Amano I, et al. 2005 Japanese Society for Dialysis Therapy guidelines for vascular access construction and repair for chronic hemodialysis [J]. Ther Apher Dial, 2006, 10(5): 449-462.
[23]
National Kidney Foundation-Kidney/Dialysis Outcomes Quality Initiative. Clinical practice guidelines for vascular access [J]. Am J Kidney Dis, 1997, 30(4 Suppl 3): S150-S191.
[1] 李刘庆, 陈小翔, 吕成余. 全腹腔镜与腹腔镜辅助远端胃癌根治术治疗进展期胃癌的近中期随访比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 23-26.
[2] 刘世君, 马杰, 师鲁静. 胃癌完整系膜切除术+标准D2根治术治疗进展期胃癌的近中期随访研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 27-30.
[3] 赵丽霞, 王春霞, 陈一锋, 胡东平, 张维胜, 王涛, 张洪来. 内脏型肥胖对腹腔镜直肠癌根治术后早期并发症的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 35-39.
[4] 李华志, 曹广, 刘殿刚, 张雅静. 不同入路下行肝切除术治疗原发性肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 52-55.
[5] 常小伟, 蔡瑜, 赵志勇, 张伟. 高强度聚焦超声消融术联合肝动脉化疗栓塞术治疗原发性肝细胞癌的效果及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 56-59.
[6] 徐逸男. 不同术式治疗梗阻性左半结直肠癌的疗效观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 72-75.
[7] 王露, 周丽君. 全腹腔镜下远端胃大部切除不同吻合方式对胃癌患者胃功能恢复、并发症发生率的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 92-95.
[8] 康婵娟, 张海涛, 翟静洁. 胰管支架置入术治疗急性胆源性胰腺炎的效果及对患者肝功能、炎症因子水平的影响[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 667-670.
[9] 付成旺, 杨大刚, 王榕, 李福堂. 营养与炎症指标在可切除胰腺癌中的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 704-708.
[10] 许杰, 李亚俊, 冯义文. SOX新辅助化疗后腹腔镜胃癌D2根治术与常规根治术治疗进展期胃癌的近期随访比较[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 647-650.
[11] 刘柏隆, 周祥福. 女性尿失禁吊带手术并发症处理的经验分享[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 127-127.
[12] 嵇振岭, 陈杰, 唐健雄. 重视复杂腹壁疝手术并发症的预防和处理[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 601-606.
[13] 江志鹏, 钟克力, 陈双. 复杂腹壁疝手术后腹腔高压与腹腔间室综合征的预防和处理[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 612-615.
[14] 王学虎, 赵渝. 复杂腹壁疝手术中血管损伤并发症的预防和处理[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 616-619.
[15] 石阳, 于剑锋, 曹可, 翟志伟, 叶春祥, 王振军, 韩加刚. 可扩张金属支架置入联合新辅助化疗治疗完全梗阻性左半结肠癌围手术期并发症分析[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 464-471.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?